埃利文斯健康公司在2025年第四季度的收益预期超过了预期,提高了2026年的预期,机构的兴趣也在增加. Elevance Health beat earnings estimates in Q4 2025, raised 2026 guidance, and saw rising institutional interest.

Elevance Health（前身为Anthem）于2026年1月28日公布了强劲的第四季度盈利，每股收益为3.33美元，超出预期0.23美元，收入为493.1亿美元，同比增长9.6%。 Elevance Health, formerly Anthem, reported strong Q4 earnings on January 28, 2026, with $3.33 EPS, beating estimates by $0.23, and revenue of $49.31 billion, up 9.6% year-over-year. 该公司将2026年的收入指导提高到每股25.50美元,宣布季度红利为17.2美元,并增加了机构利益,包括Hyperion Capital增加了46.7%的股份,Gotham资产管理增加了97.9%。 The company raised its 2026 earnings guidance to $25.50 per share, announced a quarterly dividend of $1.72, and saw increased institutional interest, including a 46.7% stake rise by Hyperion Capital and a 97.9% increase by Gotham Asset Management. 股票交易额为291.69美元,市场上限为64.38亿美元,低贝塔为0.51美元,股息收益为2.4%,辅以“多价购买”分析员共识和387.40美元平均价格目标。 The stock, trading at $291.69 with a market cap of $64.38 billion, has a low beta of 0.51 and a 2.4% dividend yield, supported by a "Moderate Buy" analyst consensus and a $387.40 average price target.